139 related articles for article (PubMed ID: 16297593)
1. Cu-Zn super oxide dismutase as a potential antifibrotic drug for hepatitis C related fibrosis.
Emerit J; Samuel D; Pavio N
Biomed Pharmacother; 2006 Jan; 60(1):1-4. PubMed ID: 16297593
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies.
Spee B; Arends B; van den Ingh TS; Brinkhof B; Nederbragt H; Ijzer J; Roskams T; Penning LC; Rothuizen J
Liver Int; 2006 Aug; 26(6):716-25. PubMed ID: 16842329
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and liver fibrosis.
Schuppan D; Krebs A; Bauer M; Hahn EG
Cell Death Differ; 2003 Jan; 10 Suppl 1():S59-67. PubMed ID: 12655347
[TBL] [Abstract][Full Text] [Related]
4. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
6. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK
Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
[TBL] [Abstract][Full Text] [Related]
7. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
8. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro.
Liu J; Wang X; Wang F; Teng L; Cao J
Biomed Pharmacother; 2009 Aug; 63(7):484-91. PubMed ID: 18602243
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.
Liu X; Hu H; Yin JQ
Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505
[TBL] [Abstract][Full Text] [Related]
11. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
[TBL] [Abstract][Full Text] [Related]
12. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
13. Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1.
Doh KO; Jung HK; Moon IJ; Kang HG; Park JH; Park JG
Int J Mol Med; 2008 Jan; 21(1):33-9. PubMed ID: 18097613
[TBL] [Abstract][Full Text] [Related]
14. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
[TBL] [Abstract][Full Text] [Related]
15. New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.
Jee MH; Hong KY; Park JH; Lee JS; Kim HS; Lee SH; Jang SK
J Virol; 2015 Dec; 90(6):3044-55. PubMed ID: 26719248
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A.
Thieringer F; Maass T; Czochra P; Klopcic B; Conrad I; Friebe D; Schirmacher P; Lohse AW; Blessing M; Galle PR; Teufel A; Kanzler S
Gene; 2008 Oct; 423(1):23-8. PubMed ID: 18598744
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing.
Schultze-Mosgau S; Kopp J; Thorwarth M; Rödel F; Melnychenko I; Grabenbauer GG; Amann K; Wehrhan F
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):280-8. PubMed ID: 16377416
[TBL] [Abstract][Full Text] [Related]
18. [Retreatment of patients with chronic hepatitis C].
Ostojić R
Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
[TBL] [Abstract][Full Text] [Related]
19. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
[TBL] [Abstract][Full Text] [Related]
20. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B].
Guo JC; Bao JF; Chen QW; Li XO; Shi JP; Lou GQ; Shi WZ; Xun YH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):354-7. PubMed ID: 19469173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
